Free Fatty Acid Receptors and Their Role in Regulation of Energy Metabolism

被引:119
作者
Hara, Takafumi [1 ,2 ]
Kimura, Ikuo [3 ]
Inoue, Daisuke [3 ]
Ichimura, Atsuhiko [4 ]
Hirasawa, Akira [3 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, World Leading Drug Discovery Res Ctr, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, Kyoto 6068501, Japan
[4] Tohoku Univ, Dept Mol Med & Therapy, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan
来源
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 164 | 2013年 / 164卷
关键词
PROTEIN-COUPLED-RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; PANCREATIC BETA-CELLS; STIMULATED INSULIN-SECRETION; ADIPOSE-TISSUE; DOUBLE-BLIND; AGONIST; FUNCTIONAL-CHARACTERIZATION; CHOLECYSTOKININ SECRETION; ENTEROENDOCRINE CELLS;
D O I
10.1007/112_2013_13
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The free fatty acid receptor (FFAR) is a G protein-coupled receptor (GPCR) activated by free fatty acids (FFAs), which play important roles not only as essential nutritional components but also as signaling molecules in numerous physiological processes. In the last decade, FFARs have been identified by the GPCR deorphanization strategy derived from the human genome database. To date, several FFARs have been identified and characterized as critical components in various physiological processes. FFARs are categorized according to the chain length of FFA ligands that activate each FFAR; FFA2 and FFA3 are activated by short chain FFAs, GPR84 is activated by medium-chain FFAs, whereas FFA1 and GPR120 are activated by medium-or long-chain FFAs. FFARs appear to act as physiological sensors for food-derived FFAs and digestion products in the gastrointestinal tract. Moreover, they are considered to be involved in the regulation of energy metabolism mediated by the secretion of insulin and incretin hormones and by the regulation of the sympathetic nerve systems, taste preferences, and inflammatory responses related to insulin resistance. Therefore, because FFARs can be considered to play important roles in physiological processes and various pathophysiological processes, FFARs have been targeted in therapeutic strategies for the treatment of metabolic disorders including type 2 diabetes and metabolic syndrome. In this review, we present a summary of recent progress regarding the understanding of their physiological roles in the regulation of energy metabolism and their potential as therapeutic targets.
引用
收藏
页码:77 / 116
页数:40
相关论文
共 128 条
[31]   Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids [J].
Ge, Hongfei ;
Li, Xiaofan ;
Weiszmann, Jennifer ;
Wang, Ping ;
Baribault, Helene ;
Chen, Jin-Long ;
Tian, Hui ;
Li, Yang .
ENDOCRINOLOGY, 2008, 149 (09) :4519-4526
[32]   Pax6 Is a Key Component of Regulated Glucagon Secretion [J].
Gosmain, Yvan ;
Cheyssac, Claire ;
Masson, Mounia Heddad ;
Guerardel, Audrey ;
Poisson, Caroline ;
Philippe, Jacques .
ENDOCRINOLOGY, 2012, 153 (09) :4204-4215
[33]   The regulation of adipogenesis through GPR120 [J].
Gotoh, Chizu ;
Hong, Yeon-Hee ;
Iga, Tomoyo ;
Hishikawa, Daisuke ;
Suzuki, Yasuki ;
Song, Sang-Houn ;
Choi, Ki-Choon ;
Adachi, Tetsuya ;
Hirasawa, Akira ;
Tsujimoto, Gozoh ;
Sasaki, Shin-ichi ;
Roh, Sang-Gun .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 354 (02) :591-597
[34]   EVIDENCE FOR REGULATION OF PEPTIDE-YY RELEASE BY THE PROXIMAL GUT [J].
GREELEY, GH ;
JENG, YJ ;
GOMEZ, G ;
HASHIMOTO, T ;
HILL, FLC ;
KERN, K ;
KUROSKY, T ;
CHUO, HF ;
THOMPSON, JC .
ENDOCRINOLOGY, 1989, 124 (03) :1438-1443
[35]   Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition [J].
Grundy, SM ;
Brewer, HB ;
Cleeman, JI ;
Smith, SC ;
Lenfant, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (02) :E13-E18
[36]   Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release [J].
Hamid, YH ;
Vissing, H ;
Holst, B ;
Urhammer, SA ;
Pyke, C ;
Hansen, SK ;
Glümer, C ;
Borch-Johnsen, K ;
Jorgensen, T ;
Schwartz, TW ;
Pedersen, O ;
Hansen, T .
DIABETIC MEDICINE, 2005, 22 (01) :74-80
[37]  
Hara T, 2012, NIHON YAKURIGAKU ZAS, V140, P257
[38]   Free Fatty Acid Receptors FFAR1 and GPR120 as Novel Therapeutic Targets for Metabolic Disorders [J].
Hara, Takafumi ;
Hirasawa, Akira ;
Ichimura, Atsuhiko ;
Kimura, Ikuo ;
Tsujimoto, Gozoh .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (09) :3594-3601
[39]   Novel selective ligands for free fatty acid receptors GPR120 and GPR40 [J].
Hara, Takafumi ;
Hirasawa, Akira ;
Sun, Qi ;
Sadakane, Keiko ;
Itsubo, Chisato ;
Iga, Tomoyo ;
Adachi, Tetsuya ;
Koshimizu, Taka-aki ;
Hashimoto, Toshihiro ;
Asakawa, Yoshinori ;
Tsujimoto, Gozoh .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 380 (03) :247-255
[40]   Flow Cytometry-Based Binding Assay for GPR40 ( FFAR1; Free Fatty Acid Receptor 1) [J].
Hara, Takafumi ;
Hirasawa, Akira ;
Sun, Qi ;
Koshimizu, Taka-Aki ;
Itsubo, Chisato ;
Sadakane, Keiko ;
Awaji, Takeo ;
Tsujimoto, Gozoh .
MOLECULAR PHARMACOLOGY, 2009, 75 (01) :85-91